KMDA logo

KMDA Kamada Ltd.

NASDAQ Global Select · Drug Manufacturers - Specialty & Generic · Healthcare

$7.74
-0.09 (-1.15%)

Kamada Ltd. is a biopharmaceutical firm focused on developing, manufacturing, and distributing protein therapeutics derived from human plasma. The company operates through two core business areas: its proprietary product segment and its distribution division. Its own manufactured portfolio includes KAMRAB/KEDRAB for rabies prevention, CYTOGAM to prevent cytomegalovirus disease in transplant recipi…

Market Cap: $446.45Mwww.kamada.com

Price

No data yet.

Social Signal Score

55
5d
50
1 mentions
—
30d
58
6 mentions
—
60d
56
8 mentions
—
90d
55
10 mentions
—
news: 10

Analyst Ratings

6 analysts
Buyconsensus
Strong Buy 0Buy 5Hold 1Sell 0Strong Sell 0
Avg price target$14+80.9%
Low $12Median $15High $15
Current Consensus

Revenue

$52.03M+114.50%
$11.65M$26.07M$40.50M$54.92M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$0.37
$0.34–$0.38
3 analysts
FY2026
$0.48+32% YoY
$0.42–$0.53
3 analysts
FY2027
$0.58+20% YoY
$0.46–$0.72
3 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Amir London
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
462
Beta
0.13
Country
IL
Piotroski score
8 / 9 (Strong)
Altman Z-score
3.52
www.kamada.com